GIC Leads $85M Series B Round In Chinese Biotech Firm Harbour BioMed
August 27, 2018 — 14:01 CST
This Data Is Locked!
This area is available only to Subscribers.
Shanghai-based biopharmaceutical company Harbour BioMed today announced that it had raised US$85 million series B round led by Government of Singapore Investment Corp (GIC).New investors... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals